Voya Investment Management LLC Sells 3,964 Shares of National Health Investors, Inc. $NHI

Key Points

• Voya Investment Management LLC reduced its stake in National Health Investors by 25.5%, selling 3,964 shares, resulting in a holding of 11,602 shares valued at approximately $857,000.
• National Health Investors recently announced an increase in its quarterly dividend from $0.90 to $0.92 per share, representing an annualized dividend yield of 4.6%.
• The company's stock has received favorable ratings from analysts, with a consensus price target of $82.25 and some upgrades to "overweight" and "strong-buy" ratings.

Voya Investment Management LLC reduced its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 25.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,602 shares of the real estate investment trust's stock after selling 3,964 shares during the period. Voya Investment Management LLC's holdings in National Health Investors were worth $857,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its stake in National Health Investors by 15.8% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust's stock worth $268,000 after acquiring an additional 495 shares in the last quarter. Bank of New York Mellon Corp grew its stake in National Health Investors by 5.6% in the 1st quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust's stock worth $43,494,000 after acquiring an additional 31,451 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in National Health Investors by 11.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust's stock worth $267,000 after acquiring an additional 357 shares in the last quarter. SG Americas Securities LLC bought a new position in National Health Investors in the 1st quarter worth about $808,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in National Health Investors by 3.3% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust's stock worth $35,372,000 after acquiring an additional 15,497 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Price Performance

Shares of NHI opened at $79.56 on Thursday. The company has a 50 day moving average price of $75.44 and a 200-day moving average price of $73.86. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $85.69. The stock has a market capitalization of $3.78 billion, a PE ratio of 25.42, a PEG ratio of 3.44 and a beta of 0.76. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91.

National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The company had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. During the same quarter in the prior year, the company posted $1.18 earnings per share. National Health Investors's revenue for the quarter was up 6.7% compared to the same quarter last year. Equities analysts predict that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a yield of 4.6%. National Health Investors's dividend payout ratio is currently 117.57%.

Wall Street Analysts Forecast Growth

NHI has been the topic of a number of research analyst reports. KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price on the stock in a research note on Thursday, July 10th. Truist Financial upped their target price on shares of National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a research note on Friday, August 15th. Wells Fargo & Company upped their price target on shares of National Health Investors from $76.00 to $80.00 and gave the stock an "equal weight" rating in a research report on Wednesday, August 27th. Finally, Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $82.25.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.